Drug-survival profiling of second-line biologic therapy in rheumatoid arthritis: Choice of another tumour necrosis factor inhibitor or a biologic of different mode of action?
Saved in:
| Title: | Drug-survival profiling of second-line biologic therapy in rheumatoid arthritis: Choice of another tumour necrosis factor inhibitor or a biologic of different mode of action? |
|---|---|
| Authors: | Shipa, Muhammad R. A.1,2 m.shipa@ucl.ac.uk, Di Cicco, Maria3, Balogh, Emese3, Nitu, Naila A.4, Mainuddin, M. D.4, Bhadauria, Naveen4, Mukerjee, Dev4, Roussou, Euthalia3 |
| Source: | Modern Rheumatology. Jul2023, Vol. 33 Issue 4, p700-707. 8p. |
| Database: | Academic Search Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
Be the first to leave a comment!
